Business Standard

Exports of Covid-19 vaccines may start in 2 weeks: SII CEO Adar Poonawalla

The vaccine manufacturer is making preparations and working on necessary regulatory protocols

Adar Poonawalla, CEO of Serum Institute of India, covid, coronavirus, vaccine
Premium

Adar Poonawalla, CEO of Serum Institute of India | Photo: twitter/Adar Poonawalla

Sohini Das Mumbai
Covid-19 vaccine exports can start in the next two weeks or so, Adar Poonawalla, chief executive of Serum Institute of India, has said. He clarified that the exports would happen only after local requirements are fully met.

Poonawalla also said that Serum Institute would start making the Novavax vaccine candidate in the country in “around two months from now." 

The vaccine manufacturer is making preparations and working on necessary regulatory protocols. Novavax vaccine is under trial in the US and there would be a bridging trial in India. 

On January 16, one of the world's largest vaccination drives kicked off in the country

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in